A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer

Locally Advanced ◽

Advanced Breast ◽

Abstract P1-11-08: A Multicenter Prospective Phase II Trial of Neo-Adjuvant (FEC 100)/Cisplatin-Docetaxel with or without Trastuzumab in Locally Advanced Breast Cancer. Gulf Oncology Research Group (G0RG-001)

10.1158/0008-5472.sabcs10-p1-11-08 ◽

2010 ◽

Author(s):

TA AL-Tweigeri ◽

AA Alsayed ◽

MM Ibrahim ◽

WM Ashaur ◽

HN Jaafar ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Oncology Research ◽

5174 Predictive factors of response to neoadjuvant 3-weekly epirubicin (EPI) plus docetaxel (DOC) chemotherapy (CT) in locally advanced breast cancer (LABC): a prospective phase II trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71066-3 ◽

2009 ◽

Vol 7 (2) ◽

pp. 312

Author(s):

M.R. Strada ◽

M. Frascaroli ◽

R. Palumbo ◽

A. Bernardo ◽

L. Villani ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Predictive Factors ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80375-7 ◽

2006 ◽

Vol 4 (2) ◽

pp. 151 ◽

Cited By ~ 1

Author(s):

M.D.F. Gaui ◽

Amorim ◽

R. Arcuri ◽

G. Pereira ◽

D. Moreira ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Cited By ~ 6

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced ◽

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80392-7 ◽

2006 ◽

Vol 4 (2) ◽

pp. 157

Author(s):

T. Al-Tweigeri ◽

Rahal ◽

D. Ajarim ◽

A. Al-Sayed ◽

A. Tulba ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80207-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S69-S70

Author(s):

G Fried

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.789 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 789-789

Author(s):

S. Karmarkar ◽

D. Jones ◽

S. Hatch ◽

F. Klementich ◽

K. Ansari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.876 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 876-876 ◽

Cited By ~ 1

Author(s):

S. X. Franco ◽

A. Perez ◽

C. Frankel ◽

E. Tan-Chiu ◽

L. Schwartzberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Preliminary Results ◽

Multicenter Phase